Investigation | Value | Reference range |
---|---|---|
Complete blood count | ||
 White blood cells | 4.46 × 109/L | 3.4–9.6 × 109/L |
  Neutrophils | 82% | 55–70% |
  Lymphocytes | 16% | 20–40% |
 Platelets | 42 × 109/L | 150–450 × 109/L |
 Hemoglobin | 13 g/dL | 13.2–16.6 g/dL |
 Hematocrit | 37% | 38.3–48.6% |
C-reactive proteins | 0–5 mg/L | |
 Day 1 | 345 mg/L |  |
 Day 7 | 19 mg/L |  |
Procalcitonin | 37.94Â ng/mL | <Â 0.15Â ng/mL |
Creatinine | 59–104 µmol/L | |
 Day 1 | 359 µmol/L |  |
 Day 2 | 414 µmol/L |  |
 Day 7 | 243 µmol/L |  |
Serum bilirubin | 62.9 mmol/L | 5.1–17 mmol/L |
 Direct | 42 mmol/L | 1.7–5.1 mmol/L |
 Indirect | 21 mmol/L | 3.4–12 mmol/L |
Arterial blood gas | ||
 pH | 7.37 | 7.35–7.45 |
 pO2 | 95 mmHg | 75–100 mmHg |
 pCO2 | 23 mmHg | 35–45 mmHg |
 HCO3− | 13 mEq/L | 22–26 mEq/L |
 Lactate | 1.1 mmol/L | 0.1–1 mmol/L |
Electrocardiogram | Widespread T inversions | Â |
2D echocardiogram | EF above 60% | |
 Day 3 | EF 30%, left ventricular global hypokinesia |  |
 Day 6 | EF 50%, improved left ventricular function |  |